drugset
drugset / Trial / NCT04689165

A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine

NCT04689165 ↗

Phase 3 Unknown 1280 enrolled Wei Cun Yunnan Center for Disease Control and Prevention · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study is a randomized, double-blinded, and controlled phase III clinical trial of the Group A meningococcal polysaccharide vaccine to evaluate the safety and immunogenicity of the vaccine in healthy infants aged 6-15 months.

Timeline

Start
2020-09-14
Primary completion
2021-05
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Control Group A meningococcal polysaccharide vaccine Vaccine — —
Subject Experimental Group A meningococcal polysaccharide vaccine Vaccine — —

Indications

meningococcal meningitis